At Index Ventures, we have modelled the early stage development process (up to proof of clinical concept) on the presumption that the majority of the risk in a discovery programme is not only unknown but it also unknowable (ahead of testing in man).
FORBES: Are We The Problem? The Role Of Poor Decision-Making In Stifling Drug Development